Shares of Telik Inc. (NASDAQ: TELK), a clinical-stage drug development company focused on the discovery and development of small molecule drugs to treat cancer, surged in trading on Wednesday.
Shares of Telik Inc. (NASDAQ: TELK), a clinical-stage drug development company focused on the discovery and development of small molecule drugs to treat cancer, surged in trading on Wednesday.